Ambey Laboratories Shines Bright with 25% Premium Debut on NSE, lists at ₹85

Ambey Laboratories debuted strongly on the NSE SME platform at ₹85 per share, a 25% premium over its ₹68 issue price, showing strong investor confidence in the company's future.
Ambey Laboratories Shines Bright with 25% Premium Debut on NSE, lists at ₹85

Ambey Laboratories made a robust market entry today as its shares debuted on the NSE SME platform at ₹85 apiece, marking a significant 25% premium over the issue price of ₹68. The strong start reflects investor confidence in the company’s prospects.

Ambey Laboratories Ltd’s IPO subscriptions opened on July 4 and closed on July 8. Each lot comprised 2,000 shares at a face value of ₹10, with the IPO price range fixed at ₹65 to ₹68 per share. By the third day, the IPO had been oversubscribed 173.18 times.

Ambey Laboratories Limited specialises in manufacturing “2, 4-D base chemicals” used in agrochemicals. Located on a 5-acre site in Behror, Rajasthan, India, the company adheres to ISO 9001:2015 and ISO 14001:2015 standards and complies with the RoHS Directive. They also produce home hygiene products such as cleaners, repellents, hand wash, and sanitizers, as well as various agrochemicals like 2,4-D Amine Salts, Acids, Esters, and Hexaconazole.

Ambey Laboratories Ltd aims to utilise INR 30.93 Crores from its IPO primarily for meeting increased working capital needs and for general corporate purposes such as enhancing marketing capabilities and strategic initiatives.

Loading
Read More News

STOP PAYING

₹ 20 BROKERAGE

ON TRADES !

Trade Intraday and Futures & Options